Carregant...

A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY

Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Endocrinol (Buchar)
Autors principals: Aydin, B., Aksu, O., Asci, H., Kayan, M., Korkmaz, H.
Format: Artigo
Idioma:Inglês
Publicat: Acta Endocrinologica Foundation 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/
https://ncbi.nlm.nih.gov/pubmed/31149244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!